Literature DB >> 8542205

In vitro duodenal iron uptake and serum and mucosal iron protein levels, with special reference to rheumatoid arthritis.

K B Raja1, P Duane, S D Snape, R J Simpson, G Papasavvas, T J Peters.   

Abstract

Duodenal biopsies from control subjects, patients with iron-deficiency anaemia and rheumatoid arthritic patients with anaemia of chronic disorders (ACD) were investigated for their ability to take up 59Fe from iron ascorbate. Additionally, duodenal tissues were analysed for iron and immunoreactive ferritin and transferrin. Biopsies from iron-deficient subjects showed a 2- to 3-fold increase in the apparent Vmax for 59Fe uptake, compared to control values. Uptake was inversely related to body iron stores. ACD patients showed similar rates of 59Fe uptake to controls; the rates were independent of the degree of anaemia or serum ferritin levels. Tissue analysis showed reductions in mucosal iron and ferritin levels in iron-deficient patients, whilst transferrin levels were within the normal range. ACD patients also exhibited lower mucosal iron levels, but had iron protein levels within the normal range. It is suggested that factors distant from the intestinal mucosa influence iron absorption in ACD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8542205     DOI: 10.1093/rheumatology/34.11.1041

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  2 in total

1.  A duodenal mucosal abnormality in the reduction of Fe(III) in patients with genetic haemochromatosis.

Authors:  K B Raja; D Pountney; A Bomford; R Przemioslo; D Sherman; R J Simpson; R Williams; T J Peters
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

2.  A nanoparticulate ferritin-core mimetic is well taken up by HuTu 80 duodenal cells and its absorption in mice is regulated by body iron.

Authors:  Gladys O Latunde-Dada; Dora I A Pereira; Bethan Tempest; Hibah Ilyas; Angela C Flynn; Mohamad F Aslam; Robert J Simpson; Jonathan J Powell
Journal:  J Nutr       Date:  2014-10-23       Impact factor: 4.798

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.